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isolates in the understanding of bioﬁlm formation capability by
these pathogens.
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Background: The Rare and Imported Pathogens Laboratory
RIPL), at the HPA Porton Down provides diagnostic services for
K clinicians for pathogenic Arboviruses. Although dengue and
hikungunya are the commonest arboviral infections globally, data
n the clinical features and epidemiology of imported dengue and
hikungunya is scarce.
Methods: Retrospective analysis from 1/1/08 until 31/12/10 of
ll cases of acute dengue fever or chikungunya fever diagnosed
hrough samples sent to RIPL and the clinical data obtained from
he referring clinician.
Cases of acute dengue were included as either dengue virus IgM
mmunoassay detected, or if dengue virus RNA was detected using
lock based polymerase chain reaction (PCR) assay or real-time
CR. Cases of chikungunya were included as laboratory conﬁrmed
PCR positive), and suspected cases (symptoms, relevant travel his-
ory and IgG positive).
Results: 178 patients (mean age 43 years) had conﬁrmed or sus-
ected chikungunya (27 in 2008, 66 in 2009, and 85 in 2010). 60%
f patients were female. The majority of patients acquired chikun-
unya infection following travel to India (37.4%). 16 patients had
ositive PCR, 43 were negative by PCR. With regards to symptoms,
hemajority described fever (74.7%), followed by arthralgia (44.9%)
r rash (24.7%).
There were 815 individual cases of acute dengue fever (183
n 2008, 188 in 2009, and 444 in 2010). 57.5% of patients were
ale and 42.5% were female, with overall mean age 38 years. Most
atients complained of fever (64.9%), rash (22.1%) or arthralgia
10.4%). Most patients acquired infection in Asia, including India
22.2%), Thailand (17.9%) and Indonesia (8%). 409 patients had PCR
erformed (negative n=143; serotype 1 n=102, serotype 2 n=91,
erotype 3 n=66 and serotype 4 n=7). There was no statistically
igniﬁcant association between serotype and symptoms.
The proportion of symptoms such as myalgia, diarrhoea, vomit-
ng, headache and rash was similar between both groups, although
rthralgia (p <0.001) and fever (p =0.012) were signiﬁcantly asso-
iated with the diagnosis of chikungunya compared with dengue.
Conclusion: In the current era of globalisation, there is a risk
f acquiring dengue and chikungunya from endemic areas, and
his study can aid clinicians in increasing awareness of the clinical
anifestations in returning travellers.
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Bioﬁlm development capability of Enterococus faecalis and
Streptococcusmutans clinical isolates under dual speciesmodel:
an in vitro study
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Background: Capability of bioﬁlm formation is an important
virulence determinant of Streptococcus mutans and Enterococcus
faecalis. Both microorganisms are highly associated with oral and
endocardial infections. Most investigations on bioﬁlm formation
have been carried out by using single species model. It is important
to understand the capability of bioﬁlm formation by S. mutans and
E. faecalis clinical isolates under dual species model.
Methods: Thirty four clinical isolates of E. faecalis and thirty
four clinical isolates of S. mutans were tested for bioﬁlm forma-
tion under dual species model by microtitre plate assay. To assess
the antimicrobial activity of chlorhexidine (CHX) against single and
dual species bioﬁlm, resazurin assay was performed.
Results: All the E. faecalis and S. mutans clinical isolates showed
strong bioﬁlm forming capability in single species model. In dual
species model, the biomass staining revealed that 78% E. faecalis
clinical isolates decreased the bioﬁlm biomass in the presence of
S. mutans bioﬁlm. This reduction is strain dependent and varied
by strain to strain. The data from resazurin assay showed that the
presence of E. faecalis in a dual species bioﬁlm resulted statisti-
cally signiﬁcant increase in resistance to a chlorhexidine treatment
(p <0.05) for all S. mutans clinical isolates.
Conclusion: Our results showed that the bioﬁlm development
capability of S. mutans clinical isolates in the presence of E. faecalis
clinical isolates was higher in dual species model. We also sug-
gested that bioﬁlm forming capability of these pathogens varied by
strain to srain. These ﬁndings substantiate the further investiga-
tions on polymicrobial bioﬁm settings with high range of clinical
